At Vitafoods Europe 2025, ADM is set to unveil an exciting new chapter in health and wellness, showcasing their range of innovative postbiotics, functional foods, and beverages. The company aims to meet the evolving consumer demands, with a particular focus on the gut-brain axis, women’s health, and holistic well-being through scientific, concept-driven solutions.
Visitors can find ADM at booth 3K109 where experts will discuss pivotal innovations in health. Highlights include the introduction of Lactobacillus gasseri CP2305. This new postbiotic specifically targets stress, mood support, and sleep, with positive outcomes demonstrated in human clinical trials, emphasising its connection to the gut-brain axis.
Another area of focus lies in microbiome solutions. Postbiotics and spore-forming probiotics are leading advancements in health offerings. Clinical research indicates these solutions effectively support various health areas, including digestive, metabolic, women’s health, and mental well-being, propelling ADM’s ongoing commitment to research and development.
ADM’s portfolio also includes a comprehensive selection of pre-, pro-, and postbiotics, along with botanical extracts and wholesome ingredients. These elements are foundational for crafting new functional food concepts that resonate with consumers, highlighting convenience and delectable taste while addressing their wellness ambitions.
Additionally, on May 20th, Dr. Richard Day, ADM’s vice president of medical affairs, will present valuable clinical data highlighting the expansive potential of postbiotics in mental, metabolic, and digestive health. This enlightening session will occur at the Nutraceutical Showcase Theatre at 4 PM.
ADM will showcase its innovative health solutions, particularly postbiotics, at Vitafoods Europe 2025. Highlights include the new Lactobacillus gasseri CP2305 for gut-brain health and a focus on microbiome solutions. The company will present a range of functional foods and disclose clinical data at the event, including a presentation by Dr. Richard Day on May 20th.
In summary, ADM’s participation at Vitafoods Europe 2025 will shine a spotlight on transformative health solutions, particularly through the innovation of postbiotics. The company’s commitment to advancing wellness through scientific research, effective microbiome solutions, and delicious functional creations aligns seamlessly with contemporary consumer needs, promising a future enriched with health-focused options. Attending Dr. Richard Day’s presentation will provide further insights into the cutting-edge research at play.
Original Source: nutraceuticalbusinessreview.com
